Shah Rukh Khan and Deepika Padukone dismissed the insider-outsider debate at a WAVES summit, emphasizing resolve and opportunities. Deepika highlighted the industry's welcoming nature and her ...

Amar Talwar who was seen in a short role in Karan Johar's Kabhi Khushi Kabhie Gham with Shah Rukh Khan, recently shared some unseen pictures of the superstar on Instagram. Fans have reacted to the ...

Amit Shah said that it is the resolve of the Narendra Modi-led NDA government to uproot terrorism from the country In the wake of the Pahalgam terror attack, Union ...

Speaking at the inaugural day of the WAVES Summit on Thursday, Shah Rukh Khan recently revealed that he enters a "meditative state" when not working. During a session titled The Journey ...

Swiss pharmaceutical giant Novartis is poised to expand its profile in the San Diego area, announcing plans to acquire Regulus Therapeutics, a local company on the cusp of bringing a potential ...

Shah Rukh Khan's not-so-small metallic hoops hung off his lobes discreetly, yet undeniably caught the eye (and light), giving him a regal and powerful feel as he walked towards the event's venue ...

Regulus Therapeutics Inc. (NASDAQ:RGLS) announced some great news today, which is that it would be acquired by Novartis AG (NVS) for $7 per share in cash. However, there is room for additional ...

Steph Miligan in Emmerdale has sparked concern with her plans to have plastic surgery, but is actress Georgia Jay leaving the soap? With Steph adamant that she will have appearance-altering ...

Bollywood star Shah Rukh Khan may join the Marvel Cinematic Universe (MCU) as a superhero soon, as per fan theories that have gone viral on social media. MarvelLeaks22, a popular Marvel fan account on ...

Novartis (NYSE:NVS) has agreed to acquire biopharmaceutical firm Regulus Therapeutics (NASDAQ:RGLS) for an initial payment of $7.00 a share in cash at closing, or $0.8B. The upfront cash portion ...

Novartis NOVN0.71%increase; green up pointing triangle has agreed to acquire Regulus Therapeutics RGLS-0.38%decrease; red down pointing triangle for a total equity value of up to roughly $1.7 ...

Novartis AG agreed to buy US biotech Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash upfront through a subsidiary ...